Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm

Trial Profile

Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Arformoterol (Primary) ; Formoterol
  • Indications Exercise-induced asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Dec 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 09 Dec 2009 Actual patient number (20) added as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top